BioRestorative Therapies Announces Participation In Adipose Tissue Biology Keystone Conference Series
JUPITER, Fla., Jan. 14, 2013 /PRNewswire/ -- BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTCBB: BRTX), a life sciences company focused on adult stem cell (non-embryonic) based cellular therapies for various personal medical applications, announced today that it has been invited to present at the Adipose Tissue Biology conference of the Keystone Symposia conference series on January 30, 2013. The Conference will be held at the Keystone Resort in Keystone, Colorado from January 27, 2013 to February 1, 2013.
BRT Chief Scientist, Francisco Silva, will be presenting the Company's research on Human Metabolically Active Brown Adipose Tissue Derived Stem Cells, which will be readily available to all organizers, speakers, and attendees of the conference. This research is a result of the scientific work BRT has been performing pursuant to its ThermoStem™ Program which focuses on treatments for metabolic disorders (diabetes, heart disease, etc.) and obesity and uses brown fat stem cells.
The Keystone Symposia on Molecular and Cellular Biology is a non-profit organization based in
Silverthorne, Colorado that was founded in 1972.
Keystone has shown unrelenting and uninhibited support for the advancement of biomedical and life sciences worldwide having convened 50-60 conferences per year across five continents. The goal of this conference is to engage researchers from diverse fields to take basic discoveries in adipocyte biology to the next level, including a deeper understanding of the etiology of type 2 diabetes and correlated diseases such as cancer, dementia and asthma through the conferences joint meeting sessions.
About BioRestorative Therapies, Inc. BioRestorative Therapies, Inc. ("BRT") develops medical procedures using cell and tissue protocols, primarily involving adult stem cells (non-embryonic), and allowing patients to undergo minimally invasive cellular-based treatments. BRT is developing the following scientific initiatives: Our brtxDISC™ Program (Disc Implanted Stem Cells) offers a non-surgical treatment for bulging and herniated discs and addresses the gap between non-invasive and invasive back procedures. Our ThermoStem™ Program focuses on treatments for metabolic disorders (diabetes, heart disease, etc.) and obesity and uses brown fat stem cells. Initial research indicates that increased amounts of brown fat in the body may be responsible for additional caloric burning as well as reduced glucose and lipid levels in the body. The Company also offers plant stem cell-based facial creams and products under the Stem Pearls® brand at www.stempearls.com.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts